We report the evaluation of two methylation-specific PCR assays for detection of methylated BCAT1 and IKZF1 DNA extracted from plasma samples from 218 colonoscopy-examined individuals (144 healthy controls and 74 CRC cases) to determine if the methylation biomarkers were complementary for detection of CRC. The gene discussed is BCAT1; the disease is colorectal carcinoma.